Large-scale testing (Phase 3)Study completedNCT03463031
What this trial is testing
Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
Who this might be right for
Seasonal Allergic Rhinitis (SAR)
Glenmark Specialty S.A. 446